Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Medpace cash
Cash and short-term investments held at the end of each period.
Medpace's cash was $705.32M at Sep 30, 2026. For fiscal 2025 it was $497.05M, down 25.8% from the year before. Over ten years it grew 39.6% a year on average. The highest annual figure on record is $669.44M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $497.05M | -25.8% |
| FY2024 | Dec 31, 2024 | $669.44M | +172.7% |
| FY2023 | Dec 31, 2023 | $245.45M | +768.4% |
| FY2022 | Dec 31, 2022 | $28.27M | -93.9% |
| FY2021 | Dec 31, 2021 | $461.30M | +66.1% |
| FY2020 | Dec 31, 2020 | $277.77M | +110.6% |
| FY2019 | Dec 31, 2019 | $131.92M | +466.6% |
| FY2018 | Dec 31, 2018 | $23.28M | -12.1% |
| FY2017 | Dec 31, 2017 | $26.49M | -29.2% |
| FY2016 | Dec 31, 2016 | $37.41M | +110.9% |
| FY2015 | Dec 31, 2015 | $17.74M | -68.0% |
| FY2014 | Dec 31, 2014 | $55.39M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $705.32M | +147.2% |
| Q2 FY2026 | Jun 30, 2026 | $502.69M | +985.0% |
| Q1 FY2026 | Mar 31, 2026 | $652.68M | +47.9% |
| Q4 FY2025 | Dec 31, 2025 | $497.05M | -25.8% |
| Q3 FY2025 | Sep 30, 2025 | $285.35M | -56.6% |
| Q2 FY2025 | Jun 30, 2025 | $46.33M | -90.9% |
| Q1 FY2025 | Mar 31, 2025 | $441.44M | +8.5% |
| Q4 FY2024 | Dec 31, 2024 | $669.44M | +172.7% |
| Q3 FY2024 | Sep 30, 2024 | $656.90M | +590.0% |
| Q2 FY2024 | Jun 30, 2024 | $510.89M | +1205.4% |
| Q1 FY2024 | Mar 31, 2024 | $407.01M | +767.4% |
| Q4 FY2023 | Dec 31, 2023 | $245.45M | +768.4% |
| Q3 FY2023 | Sep 30, 2023 | $95.21M | +207.1% |
| Q2 FY2023 | Jun 30, 2023 | $39.14M | -8.0% |
| Q1 FY2023 | Mar 31, 2023 | $46.92M | -43.4% |
| Q4 FY2022 | Dec 31, 2022 | $28.27M | -93.9% |
| Q3 FY2022 | Sep 30, 2022 | $31.01M | -92.2% |
| Q2 FY2022 | Jun 30, 2022 | $42.55M | -87.4% |
| Q1 FY2022 | Mar 31, 2022 | $82.84M | -75.1% |
| Q4 FY2021 | Dec 31, 2021 | $461.30M | +66.1% |
| Q3 FY2021 | Sep 30, 2021 | $398.39M | +81.7% |
| Q2 FY2021 | Jun 30, 2021 | $339.01M | +110.7% |
| Q1 FY2021 | Mar 31, 2021 | $332.88M | +148.4% |
| Q4 FY2020 | Dec 31, 2020 | $277.77M | +110.6% |
| Q3 FY2020 | Sep 30, 2020 | $219.23M | +176.5% |
| Q2 FY2020 | Jun 30, 2020 | $160.90M | +700.6% |
| Q1 FY2020 | Mar 31, 2020 | $134.00M | +344.8% |
| Q4 FY2019 | Dec 31, 2019 | $131.92M | +466.6% |
| Q3 FY2019 | Sep 30, 2019 | $79.29M | +256.5% |
| Q2 FY2019 | Jun 30, 2019 | $20.10M | -9.6% |
| Q1 FY2019 | Mar 31, 2019 | $30.13M | +35.4% |
| Q4 FY2018 | Dec 31, 2018 | $23.28M | -12.1% |
| Q3 FY2018 | Sep 30, 2018 | $22.24M | -8.3% |
| Q2 FY2018 | Jun 30, 2018 | $22.23M | -24.2% |
| Q1 FY2018 | Mar 31, 2018 | $22.25M | -24.8% |
| Q4 FY2017 | Dec 31, 2017 | $26.49M | -29.2% |
| Q3 FY2017 | Sep 30, 2017 | $24.25M | – |
| Q2 FY2017 | Jun 30, 2017 | $29.33M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.41M | – |
See a number that looks wrong?